Halophenol Rearrangement
825
2-Hydroxyanthraquinone 12[21]
Yellow amorphous solid, mp 298–299◦C. δH 11.08 (br s, 1H, 2-
OH), 8.17 (m, 2H, H5, H8), 8.10 (d, 1H, J 8.5, H4), 7.90 (m, 2H,
H6, H7), 7.51 (d, 1H, J 2.5, H1), 7.25 (dd, 1H, J 8.5, 2.5, H3). δC
183.4 (C9), 181.9 (C10), 163.8 (C2), 135.9 (C13), 135.3 (C7),
134.7 (C6), 133.9 (C12), 133.8 (C11), 130.6 (C4), 127.3 (C8),
127.3 (C5), 125.9 (C14), 122.3 (C3), 112.9 (C1). νmax/cm−1
3370, 1672, 1578. m/z (EI) 224 (100%, [M+]), 196 (35), 168
(35), 139 (78), 113 (9), 98 (7), 84 (12), 63 (21).
UV, IR, mass, 1H NMR, and 13C NMR spectra, and the structures
that were also confirmed by their correlation spectroscopy,
heteronuclear single-quantum correlation, and HMBC spectra
are available from the journal’s website.
Acknowledgements
The authors thank University Putra Malaysia and the Ministry of Science,
Technology and Innovation for the funds provided under the Scientific
Advancement Grant Allocation (SAGA) research funding program.
1-Bromo-3-hydroxyanthraquinone 13
Yellow amorphous solid, mp 180–181◦C. δH 11.50 (br s, 1H, 3-
OH), 8.14 (m, 2H, H5, H8), 7.90 (m, 2H, H6, H7), 7.59 (d, 1H,
J 2.5, H4), 7.46 (d, 1H, J 2.5, H2). δC 182.3 (C10), 180.6 (C9),
162.5 (C3), 138.2 (C14), 135.5 (C6), 134.8 (C11), 134.5 (C7),
132.8 (C12), 128.1 (C2), 127.6 (C5), 126.9 (C8), 124.2 (C1),
122.9 (C13), 114.3 (C4). νmax/cm−1 3393, 1655, 1576. m/z (EI)
304 (22%, [M+ + 2]), 302 (24, [M+]), 276 (11), 274 (11), 248
(8), 246 (9), 223 (6), 195 (14), 167 (17), 139 (100), 113 (13), 87
(12), 69 (23), 50 (38). HREIMS m/z (%): 303.9563 ([M+], 99,
required 303.9558), 301.9581 ([M+], 100, required 301.9579).
References
[1] V. Gonnot, S. Tisserand, M. Nicolas, R. Baati, C. Mioskowski, Tetra-
hedron Lett. 2007, 48, 7117. doi:10.1016/J.TETLET.2007.07.218
[2] R. C. Cambie, P. S. Rutledge, P. D. Woodgate, Aust. J. Chem. 1992,
45, 483. doi:10.1071/CH9920483
[3] S. Gattinoni, L. Merlini, S. Dallavalle, Tetrahedron Lett. 2007, 48,
1049. doi:10.1016/J.TETLET.2006.11.164
[4] B. N. Lenta, B. Weniger, C. Antheaume, D. T. Noungoue,
S. Ngouela, J. C. N. Assob, C. Vonthron-Senecheau, P. A. Fokou,
K. P. Devkota, E. Tsamo, N. Sewald, Phytochemistry 2007, 68, 1595.
doi:10.1016/J.PHYTOCHEM.2007.03.037
[5] B. Onegi, C. Kraft, I. Kohler, M. Freund, K. J. Siems, K. Siems,
G. Bayer, M. F. Melzig, U. Bienzle, E. Eich, Phytochemistry 2002,
60, 39. doi:10.1016/S0031-9422(02)00072-9
[6] Y. Igarashi, M. E. Trujillo, E. Martinez-Molina, S. Yanase,
S. Miyanaga, T. Obata, H. Sakurai, I. Saiki, T. Fujita, T. Furumai,
Bioorg. Med. Chem. Lett. 2007, 17, 3702. doi:10.1016/J.BMCL.
2007.04.039
1-Bromo-2-hydroxyanthraquinone 14
Yellow crystals, mp 184–185◦C. δH 11.90 (br s, 1H, 2-OH), 8.12
(m, 3H, H5, H8, H4), 7.88 (m, 2H, H6, H7), 7.38 (d, 1H, J
8.5, H3). δC 182.7 (C9), 181.5 (C10), 161.4 (C2), 135.0 (C7),
134.9 (C12), 134.8 (C6), 133.1 (C13), 132.7 (C11), 129.5 (C4),
128.1 (C14), 127.6 (C8), 126.7 (C5), 120.8 (C3), 110.3 (C1).
νmax/cm−1 3548, 1675, 1589. m/z (EI) 304 (90%, [M+ + 2]),
302 (100, [M+]), 276 (30), 274 (28), 248 (18), 246 (19), 223
(16), 195 (14), 167 (19), 139 (69), 124 (14), 91 (7), 69 (37).
HREIMS m/z (%): 303.9560 ([M+], 97, required 303.9558),
301.9579 ([M+], 100, required 301.9579).
[7] Y.-T. Su, H.-L. Chang, S.-K. Shyue, S.-L. Hsu, Biochem. Pharmacol.
2005, 70, 229. doi:10.1016/J.BCP.2005.04.026
[8] A. M. Ali, N. H. Ismail, M. M. Mackeen, L. S. Yazan,
S. M. Mohamed, A. S. H. Ho, N. H. Lajis, Pharm. Biol. 2000, 38,
298. doi:10.1076/1388-0209(200009)38:4;1-A;FT298
[9] M. C. Cardia, M. Begala, A. DeLogu, E. Maccioni, Il Farmaco 2001,
56, 549. doi:10.1016/S0014-827X(01)01082-5
[10] B.-L. Wei, S.-H. Wu, M.-I. Chung, S.-J. Won, C.-N. Lin, Eur. J. Med.
Chem. 2000, 35, 1089. doi:10.1016/S0223-5234(00)01190-9
[11] H. Sadeghi-Aliabadi, M. Tabarzadi, A. Zarghi, Il Farmaco 2004, 59,
645. doi:10.1016/J.FARMAC.2004.03.006
[12] G. A. Kraus, W. Zhang, Bioorg. Med. Chem. Lett. 1995, 5, 2633.
doi:10.1016/0960-894X(95)00458-6
[13] P. G. Sammes, D. J. Dodsworth, J. Chem. Soc. Chem. Commun. 1979,
33. doi:10.1039/C39790000033
[14] P. Ge, R.A. Russell,Tetrahedron 1997, 53, 17469. doi:10.1016/S0040-
4020(97)10195-8
4-Chloro-1-hydroxyanthraquinone 15
Yellow needles, mp 190–191◦C. δH 13.28 (s, 1H, 1-OH), 8.32 (m,
2H, H5, H8), 7.84 (m, 2H, H6, H7), 7.69 (d, 1H, J 9.0, H3), 7.27
(d, 1H, J 9.0, H2). δC 188.5 (C9), 181.5 (C10), 162.6 (C1), 140.9
(C3), 135.4 (C7), 134.6 (C12), 134.2 (C6), 132.3 (C11), 128.9
(C4), 127.9 (C8), 126.9 (C5), 126.7 (C14), 125.5 (C2), 117.4
(C13). νmax/cm−1 3455, 1640. m/z (EI) 260 (35%, [M+ + 2]),
258 (100, [M+]), 232 (10), 230 (26), 204 (11), 202 (33), 167
(10), 139 (52), 113 (6), 87 (5), 69 (6), 50 (3). HREIMS m/z (%):
260.0056 ([M+], 33, required 260.0054), 258.0082 ([M+], 100,
required 258.0084).
[15] F. M. Hauser, S. Prasanna, J. Org. Chem. 1982, 47, 383.
doi:10.1021/JO00341A050
[16] B. Zacharie, G.Attardo, N. Barriault, C. Penney, J. Chem. Soc., Perkin
Trans. 1 1997, 2925. doi:10.1039/A701102D
[17] J. C. Jacquesy, M. P. Jouannetaud, Tetrahedron Lett. 1982, 23, 1673.
doi:10.1016/S0040-4039(00)87187-7
General Procedure for Halophenol Rearrangement
[18] S. Adimurthy, G. Ramachandraiah, A. V. Bedekar, Tetrahedron Lett.
2003, 44, 6391. doi:10.1016/S0040-4039(03)01617-4
[19] M. A. Kunz, G. F. van Rosenberg, German Patent DE 484665 1927.
[20] F. M. Hausser, C. Takeuchi, H.Yin, S. A. Corlett, J. Org. Chem. 1994,
59, 258. doi:10.1021/JO00080A047
Halophenol or haloanisole (1.16 mmol) was introduced into a
melt of AlCl3 (1.55 g, 11.6 mmol) and NaCl (0.31 g, 5.3 mmol)
at 120–130◦C (external temperature). The mixture was heated
with stirring for 10 min at that temperature. After cooling, the
melt was decomposed by the addition of a mixture of ice and
hydrochloric acid. The acidic mixture was briefly heated under
reflux and then extracted with ethyl acetate.
[21] C. Brisson, P. Brassard, J. Org. Chem. 1981, 46, 1810.
doi:10.1021/JO00322A012